Summary

The global SNP Genotyping and Analysis market size was US$ 1873 million in 2024 and is forecast to a readjusted size of US$ 5475 million by 2031 with a CAGR of 16.8% during the forecast period 2025-2031.
A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions. In some cases, this variation results in the one minor allele causing or predisposing the individual to have a certain disease or trait. The SNP Genotyping and Analysis industry can be broken down into several segments, Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays, etc.
Global key players of SNP genotyping and analysis include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, etc. Global top five manufacturers hold a share over 87%. The key players are mainly located in Europe and North America. In terms of product, dynamic allele-Specific hybridization is the largest segment, with a share over 48%. And in terms of application, the largest application is pharmaceuticals and pharmacogenomics, with a share over 52%.

The global SNP Genotyping and Analysis market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation
By Company:
Thermo Fisher Scientific
Illumina
Agilent Technologies
Roche
Bio-rad
LGC
Sequenom
Beckman Coulter
QIAGEN
Fluidigm
By Type: (Dominant Segment vs High-Margin Innovation)
Dynamic Allele-Specific Hybridization
Molecular Beacons
SNP Microarrays
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Breeding and Animal Livestock
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher Scientific in Europe)
- Emerging Product Trends: Dynamic Allele-Specific Hybridization adoption vs. Molecular Beacons premiumization
- Demand-Side Dynamics: Pharmaceuticals and Pharmacogenomics growth in China vs. Diagnostic Research potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
(Additional regions can be customized based on client needs.)

Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of SNP Genotyping and Analysis market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Molecular Beacons in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnostic Research in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the SNP Genotyping and Analysis value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Dynamic Allele-Specific Hybridization
1.2.3 Molecular Beacons
1.2.4 SNP Microarrays
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals and Pharmacogenomics
1.3.3 Diagnostic Research
1.3.4 Agricultural Biotechnology
1.3.5 Breeding and Animal Livestock
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global SNP Genotyping and Analysis Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global SNP Genotyping and Analysis Revenue Market Share by Region (2020-2025)
2.4 Global SNP Genotyping and Analysis Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America SNP Genotyping and Analysis Market Size and Prospective (2020-2031)
2.5.2 Europe SNP Genotyping and Analysis Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global SNP Genotyping and Analysis Historic Market Size by Type (2020-2025)
3.2 Global SNP Genotyping and Analysis Forecasted Market Size by Type (2026-2031)
3.3 Different Types SNP Genotyping and Analysis Representative Players
4 Breakdown Data by Application
4.1 Global SNP Genotyping and Analysis Historic Market Size by Application (2020-2025)
4.2 Global SNP Genotyping and Analysis Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in SNP Genotyping and Analysis Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top SNP Genotyping and Analysis Players by Revenue (2020-2025)
5.1.2 Global SNP Genotyping and Analysis Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by SNP Genotyping and Analysis Revenue
5.4 Global SNP Genotyping and Analysis Market Concentration Analysis
5.4.1 Global SNP Genotyping and Analysis Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by SNP Genotyping and Analysis Revenue in 2024
5.5 Global Key Players of SNP Genotyping and Analysis Head office and Area Served
5.6 Global Key Players of SNP Genotyping and Analysis, Product and Application
5.7 Global Key Players of SNP Genotyping and Analysis, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America SNP Genotyping and Analysis Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America SNP Genotyping and Analysis Market Size by Type (2020-2025)
6.1.2.2 North America SNP Genotyping and Analysis Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America SNP Genotyping and Analysis Market Size by Application (2020-2025)
6.1.3.2 North America SNP Genotyping and Analysis Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe SNP Genotyping and Analysis Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe SNP Genotyping and Analysis Market Size by Type (2020-2025)
6.2.2.2 Europe SNP Genotyping and Analysis Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe SNP Genotyping and Analysis Market Size by Application (2020-2025)
6.2.3.2 Europe SNP Genotyping and Analysis Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific SNP Genotyping and Analysis Introduction
7.1.4 Thermo Fisher Scientific Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Illumina
7.2.1 Illumina Company Details
7.2.2 Illumina Business Overview
7.2.3 Illumina SNP Genotyping and Analysis Introduction
7.2.4 Illumina Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.2.5 Illumina Recent Development
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Details
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies SNP Genotyping and Analysis Introduction
7.3.4 Agilent Technologies Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.3.5 Agilent Technologies Recent Development
7.4 Roche
7.4.1 Roche Company Details
7.4.2 Roche Business Overview
7.4.3 Roche SNP Genotyping and Analysis Introduction
7.4.4 Roche Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.4.5 Roche Recent Development
7.5 Bio-rad
7.5.1 Bio-rad Company Details
7.5.2 Bio-rad Business Overview
7.5.3 Bio-rad SNP Genotyping and Analysis Introduction
7.5.4 Bio-rad Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.5.5 Bio-rad Recent Development
7.6 LGC
7.6.1 LGC Company Details
7.6.2 LGC Business Overview
7.6.3 LGC SNP Genotyping and Analysis Introduction
7.6.4 LGC Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.6.5 LGC Recent Development
7.7 Sequenom
7.7.1 Sequenom Company Details
7.7.2 Sequenom Business Overview
7.7.3 Sequenom SNP Genotyping and Analysis Introduction
7.7.4 Sequenom Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.7.5 Sequenom Recent Development
7.8 Beckman Coulter
7.8.1 Beckman Coulter Company Details
7.8.2 Beckman Coulter Business Overview
7.8.3 Beckman Coulter SNP Genotyping and Analysis Introduction
7.8.4 Beckman Coulter Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.8.5 Beckman Coulter Recent Development
7.9 QIAGEN
7.9.1 QIAGEN Company Details
7.9.2 QIAGEN Business Overview
7.9.3 QIAGEN SNP Genotyping and Analysis Introduction
7.9.4 QIAGEN Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.9.5 QIAGEN Recent Development
7.10 Fluidigm
7.10.1 Fluidigm Company Details
7.10.2 Fluidigm Business Overview
7.10.3 Fluidigm SNP Genotyping and Analysis Introduction
7.10.4 Fluidigm Revenue in SNP Genotyping and Analysis Business (2020-2025)
7.10.5 Fluidigm Recent Development
8 SNP Genotyping and Analysis Market Dynamics
8.1 SNP Genotyping and Analysis Industry Trends
8.2 SNP Genotyping and Analysis Market Drivers
8.3 SNP Genotyping and Analysis Market Challenges
8.4 SNP Genotyping and Analysis Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer